Hemodynamics of dexamethasone-induced hypertension in the rat

被引:0
|
作者
Sharon Leng Hong Ong
Yi Zhang
Matthew Sutton
Judith Ann Whitworth
机构
[1] High Blood Pressure Research Unit,
[2] John Curtin School of Medical Research,undefined
[3] Australian National University,undefined
来源
Hypertension Research | 2009年 / 32卷
关键词
dexamethasone; hemodynamics; minoxidil; total peripheral resistance;
D O I
暂无
中图分类号
学科分类号
摘要
Although dexamethasone (DEX) is known to cause hypertension in humans and in animals, the hemodynamic characteristics of DEX-induced hypertension (DEX-HT) in the rat remain unclear. This study evaluated central and regional hemodynamics, and the role of total peripheral resistance (TPR) using a vasodilator minoxidil. Rats were divided into four groups, namely saline (n=20), DEX (n=21), minoxidil+saline (n=10) and minoxidil+DEX (n=10). Tail-cuff systolic blood pressure was recorded every second day. After 10–14 days of treatment, central (saline: n=9, DEX: n=10) and regional (saline: n=11, DEX: n=11) hemodynamic parameters were measured. Central hemodynamic data were also obtained from minoxidil-treated rats. DEX increased blood pressure (P<0.0005) in association with an increase in TPR (P<0.05). However, individual assessments of renal, mesenteric and hindquarter circulations did not detect any significant increase in resistance in these beds. Minoxidil increased cardiac output (P′<0.01) and cardiac index (P′<0.005) as well as decreased TPR (P′<0.05) without affecting DEX-HT. DEX prevented weight gain and decreased thymus weight. The increase in TPR in DEX-HT in rats was not simply explained by isolated alterations to resistance in the renal, mesenteric or hindquarter circulations. Minoxidil effectively prevented the increase in TPR but not the increase in blood pressure, suggesting that an increase in TPR is not essential for DEX-induced blood pressure increase.
引用
收藏
页码:889 / 894
页数:5
相关论文
共 50 条
  • [21] Inhibition of tyrosine hydroxylase reduces dexamethasone-induced hypertension
    Soto-Pina, Alexandra Estela
    Kadapakkam, Sheela
    Mehring, Cinthya
    Hinojosa-Laborde, Carmen
    Strong, Randy
    [J]. FASEB JOURNAL, 2011, 25
  • [22] Role of xanthine oxidase in dexamethasone-induced hypertension in rats
    Ong, Sharon L. H.
    Vickers, Janine J.
    Zhang, Yi
    McKenzie, Katja U. S.
    Walsh, Claire E.
    Whitworth, Judith A.
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2007, 34 (5-6) : 517 - 519
  • [23] PLASMA-CONCENTRATIONS, RENAL EXCRETION, AND TISSUE RELEASE OF PROSTAGLANDINS IN THE RAT WITH DEXAMETHASONE-INDUCED HYPERTENSION
    NASJLETTI, A
    ERMAN, A
    CAGEN, LM
    BAER, PG
    MATTHEWS, C
    KILLMAR, JT
    [J]. ENDOCRINOLOGY, 1984, 114 (03) : 1033 - 1040
  • [24] The NAD(P)H oxidase inhibitor apocynin reverses and prevents dexamethasone-induced hypertension in the rat
    Hu, L
    Zhang, Y
    Lim, PS
    Schyvens, CG
    McKenzie, KU
    Whitworth, JA
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2005, 32 (07) : A20 - A21
  • [25] Xanthine oxidase activity in the dexamethasone-induced hypertensive rat
    Wallwork, CJ
    Parks, DA
    Schmid-Schönbein, GW
    [J]. MICROVASCULAR RESEARCH, 2003, 66 (01) : 30 - 37
  • [26] DEXAMETHASONE-INDUCED ALTERATIONS IN THE GLYCOSPHINGOLIPIDS OF RAT-KIDNEY
    DAHIYA, R
    BRASITUS, TA
    [J]. LIPIDS, 1988, 23 (09) : 863 - 868
  • [27] Ultrastructural Changes Associated With Dexamethasone-Induced Ocular Hypertension in Mice
    Overby, Darryl R.
    Bertrand, Jacques
    Tektas, Ozan-Yueksel
    Boussommier-Calleja, Alexandra
    Schicht, Martin
    Ethier, C. Ross
    Woodward, David F.
    Stamer, W. Daniel
    Luetjen-Drecoll, Elke
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (08) : 4922 - 4933
  • [28] Dexamethasone-induced hiccup
    de Arriba Mendez, Jose Javier
    [J]. MEDICINA CLINICA, 2016, 146 (06): : 284 - 284
  • [29] DEXAMETHASONE-INDUCED BRADYCARDIA
    PUNTIS, JWL
    MORGAN, MEI
    DURBIN, GM
    [J]. LANCET, 1988, 2 (8624): : 1372 - 1372
  • [30] Dexamethasone-induced hepatomegaly
    Perez, Alvaro Villarejo
    Garcia, Emilio Garcia
    [J]. MEDICINA CLINICA, 2024, 162 (08): : 400 - 401